Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Diabetes

  Free Subscription


09.12.2024

2 Am J Clin Nutr
2 Am J Ophthalmol
1 Ann Intern Med
1 Biochem Biophys Res Commun
1 BMJ
1 Diabet Med
1 Diabetes
4 Diabetes Care
10 Diabetes Obes Metab
5 Diabetologia
1 J Am Coll Cardiol
1 J Clin Invest
3 J Diabetes Complications
1 J Nutr
1 Nutr Metab (Lond)
1 Ophthalmology
1 Pediatrics
1 PLoS Genet
17 PLoS One
1 Retina


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Nutr

  1. THOMSEN MN, Skytte MJ, Samkani A, Weber P, et al
    Replacing dietary carbohydrate with protein and fat improves lipoprotein subclass profile and liver fat in type 2 diabetes independent of body weight: evidence from two randomized controlled trials.
    Am J Clin Nutr. 2024 Nov 29:S0002-9165(24)01425.
    PubMed         Abstract available

  2. GIOSUE A, Skantze V, Hjorth T, Hjort A, et al
    Association of the glucose patterns after a single non-standardized meal with the habitual diet composition and features of the daily glucose profile in individuals without diabetes.
    Am J Clin Nutr. 2024 Nov 28:S0002-9165(24)01423.
    PubMed         Abstract available


    Am J Ophthalmol

  3. MOU K, Zhang M
    Comment on "Retinal and Choroidal Phenotypes Across Novel Subtypes of Type 2 Diabetes Mellitus".
    Am J Ophthalmol. 2024 Nov 28:S0002-9394(24)00546.
    PubMed        

  4. LIU K, Li T, Zhong P, Zhu Z, et al
    Reply to Comment on "Retinal and Choroidal Phenotypes Across Novel Subtypes of Type 2 Diabetes Mellitus".
    Am J Ophthalmol. 2024 Nov 28:S0002-9394(24)00547.
    PubMed        


    Ann Intern Med

  5. VASSILOPOULOS S, Mylonakis E
    After COVID-19 diagnosis, risk for incident type 2 diabetes was elevated for up to 2 y.
    Ann Intern Med. 2024 Dec 3. doi: 10.7326/ANNALS-24-02887.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  6. FU Y, Tang M, Duan Y, Pan Y, et al
    MOTS-c regulates the ROS/TXNIP/NLRP3 pathway to alleviate diabetic cardiomyopathy.
    Biochem Biophys Res Commun. 2024;741:151072.
    PubMed         Abstract available


    BMJ

  7. LIU B, Zong G, Zhu L, Hu Y, et al
    Chocolate intake and risk of type 2 diabetes: prospective cohort studies.
    BMJ. 2024;387:e078386.
    PubMed         Abstract available


    Diabet Med

  8. QUINN LM, Dias RP, Greenfield SM, Richter AG, et al
    Protocol for a feasibility and acceptability study for UK general population paediatric type 1 diabetes screening-the EarLy Surveillance for Autoimmune diabetes (ELSA) study.
    Diabet Med. 2024 Dec 2:e15490. doi: 10.1111/dme.15490.
    PubMed         Abstract available


    Diabetes

  9. LIM CGY, Ozkan B, Liang Y, Chen J, et al
    Plasma proteomic signatures of adiposity are associated with cardiovascular risk factors and type 2 diabetes risk in a multi-ethnic Asian population.
    Diabetes. 2024 Dec 2:db240184. doi: 10.2337/db24-0184.
    PubMed         Abstract available


    Diabetes Care

  10. HIRSCH IB, Beck RW, Marak MC, Kudva Y, et al
    A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults With Type 1 Diabetes.
    Diabetes Care. 2024 Dec 6:dc241832. doi: 10.2337/dc24-1832.
    PubMed         Abstract available

  11. MCGRAIL C, Chiou J, Egamal R, Luckett AM, et al
    Genetic Discovery and Risk Prediction for Type 1 Diabetes in Individuals Without High-Risk HLA-DR3/DR4 Haplotypes.
    Diabetes Care. 2024 Dec 3:dc241251. doi: 10.2337/dc24-1251.
    PubMed         Abstract available

  12. GARG N, Lewis K, White PC, Adhikari S, et al
    Continuous Glucose Monitor Accuracy for Diabetes Management in Hospitalized Children.
    Diabetes Care. 2024 Dec 2:dc241562. doi: 10.2337/dc24-1562.
    PubMed         Abstract available

  13. NEUMILLER JJ, Bajaj M, Bannuru RR, McCoy RG, et al
    Compounded GLP 1 and Dual GIP/GLP 1 Receptor Agonists: A Statement from the American Diabetes Association.
    Diabetes Care. 2024 Dec 2:dci240091. doi: 10.2337/dci24-0091.
    PubMed         Abstract available


    Diabetes Obes Metab

  14. LOU Y, Xie Y, Jiang Q, Huang S, et al
    The effect of sarcopenic obesity on glycaemic status based on fasting plasma glucose and glycated haemoglobin: A prospective cohort study.
    Diabetes Obes Metab. 2025;27:291-299.
    PubMed         Abstract available

  15. BAEK S, Park J, Chung JY, Kwak SH, et al
    Short-term efficacy and safety of metformin in individuals with type 2 diabetes and mild hepatic impairment: A propensity score-matched real-world study.
    Diabetes Obes Metab. 2024 Dec 6. doi: 10.1111/dom.16108.
    PubMed        

  16. WANG G, Fu J, Li X, Wang J, et al
    Comparative efficacy and safety of dipeptidyl peptidase-4 inhibitors in adults with type 2 diabetes mellitus: A network meta-analysis.
    Diabetes Obes Metab. 2024 Dec 6. doi: 10.1111/dom.16114.
    PubMed         Abstract available

  17. BAO Y, Hu Y, Shi M, Zhao Z, et al
    SGLT2 inhibitors reduce epicardial adipose tissue more than GLP-1 agonists or exercise interventions in patients with type 2 diabetes mellitus and/or obesity: A systematic review and network meta-analysis.
    Diabetes Obes Metab. 2024 Dec 6. doi: 10.1111/dom.16107.
    PubMed         Abstract available

  18. LI M, Yu H, Wan S, Hu F, et al
    The fibrosis investigating navigator in diabetes (FIND): A tool to predict liver fibrosis risk in subjects with diabetes.
    Diabetes Obes Metab. 2024 Dec 5. doi: 10.1111/dom.16109.
    PubMed         Abstract available

  19. FINKELSTEIN EA, Gardner DS, Tham KW, Gandhi M, et al
    Effectiveness and cost-effectiveness of an app and rewards-based intervention in type 2 diabetes: A randomised controlled trial.
    Diabetes Obes Metab. 2024 Dec 5. doi: 10.1111/dom.16067.
    PubMed         Abstract available

  20. WANG X, Pei J, Zheng K, Liu M, et al
    The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes.
    Diabetes Obes Metab. 2024 Dec 3. doi: 10.1111/dom.16112.
    PubMed         Abstract available

  21. ZOU Y, Jiang F, Sun C, Zhao C, et al
    Safety, pharmacokinetics and pharmacodynamics of multiple-dose noiiglutide (SHR20004), a novel GLP-1 receptor agonist, in Chinese obese subjects without diabetes mellitus.
    Diabetes Obes Metab. 2024 Dec 1. doi: 10.1111/dom.16080.
    PubMed         Abstract available

  22. LIU R, Zhang J, Chen S, Xiao Y, et al
    Intestinal mucosal immunity and type 1 diabetes: Non-negligible communication between gut and pancreas.
    Diabetes Obes Metab. 2024 Dec 1. doi: 10.1111/dom.16101.
    PubMed         Abstract available

  23. JIAO R, Lin C, Cai X, Wang J, et al
    Characterizing body composition modifying effects of a glucagon-like peptide 1 receptor-based agonist: A meta-analysis.
    Diabetes Obes Metab. 2025;27:259-267.
    PubMed         Abstract available


    Diabetologia

  24. CHEN Y, Torta F, Koh HWL, Benke PI, et al
    Metabolomics profiling in multi-ancestral individuals with type 2 diabetes in Singapore identified metabolites associated with renal function decline.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06324.
    PubMed         Abstract available

  25. VIRTANEN JK, Hantunen S, Kallio N, Lamberg-Allardt C, et al
    The effect of vitamin D(3) supplementation on the incidence of type 2 diabetes in healthy older adults not at high risk for diabetes (FIND): a randomised controlled trial.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06336.
    PubMed         Abstract available

  26. JONES DL, Kusinski LC, Gillies C, Meek CL, et al
    A critique of measurement of defective insulin secretion and insulin sensitivity as a precision approach to gestational diabetes.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06334.
    PubMed         Abstract available

  27. MACKENBACH JD, Stuber JM, Beulens JWJ
    Evidence on the effectiveness and equity of population-based policies to reduce the burden of type 2 diabetes: a narrative review.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06330.
    PubMed         Abstract available

  28. BROWN ME, Thirawatananond P, Peters LD, Kern EJ, et al
    Inhibition of CD226 co-stimulation suppresses diabetes development in the NOD mouse by augmenting regulatory T cells and diminishing effector T cell function.
    Diabetologia. 2024 Dec 5. doi: 10.1007/s00125-024-06329.
    PubMed         Abstract available


    J Am Coll Cardiol

  29. WARRAICH HJ, Patrick-Lake B, Saha A, Rashid L, et al
    Digital Health Technologies for Cardiometabolic Disease and Diabetes: A Perspective From the U.S. Food and Drug Administration.
    J Am Coll Cardiol. 2024 Nov 19:S0735-1097(24)10028.
    PubMed        


    J Clin Invest

  30. CATTIN-ROY AN, Laffey KG, Le LB, Schrum AG, et al
    Reduced thymic IL-4 impairs negative T cell selection in nonobese diabetic mice.
    J Clin Invest. 2024;134:e163417.
    PubMed         Abstract available


    J Diabetes Complications

  31. YOKOMICHI H, Mochizuki M, Suzuki S, Ito Y, et al
    Slowly progressive subtype of childhood-onset type 1 diabetes as a high-risk factor for end-stage renal disease: A cohort study in Japan.
    J Diabetes Complications. 2024;39:108922.
    PubMed         Abstract available

  32. CARDOSO CRL, da Silva Pereira L, Leite NC, Salles GF, et al
    Prognostic importance of baseline and changes in serum uric acid for macro/microvascular and mortality outcomes in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort.
    J Diabetes Complications. 2024;39:108921.
    PubMed         Abstract available

  33. HONG SH, Jee Y, Sung YA, Hong YS, et al
    Impact of visit-to-visit glycated hemoglobin variability on diabetes distress and its subscales.
    J Diabetes Complications. 2024;39:108924.
    PubMed         Abstract available


    J Nutr

  34. WANG Q, Schmidt AF, Wannamethee SG
    Prospective association of the Mediterranean diet with the onset of cardiometabolic multimorbidity in a UK-based cohort: the EPIC-Norfolk study.
    J Nutr. 2024 Oct 16:S0022-3166(24)01104-0. doi: 10.1016/j.tjnut.2024.
    PubMed         Abstract available


    Nutr Metab (Lond)

  35. WANG Z, Wang H, Chen Y, Chen Y, et al
    Deciphering the role of oleic acid in diabetic retinopathy: an empirical analysis of monounsaturated fatty acids.
    Nutr Metab (Lond). 2024;21:97.
    PubMed         Abstract available


    Ophthalmology

  36. CHUANG SH, Chang CH
    Re: Muayad et al.: Comparative effects of GLP-1 receptor agonists and metformin on glaucoma risk in type 2 diabetes patients (Ophthalmology. Aug 23 2024;doi:10.1016/j.ophtha.2024.08.023).
    Ophthalmology. 2024 Nov 28:S0161-6420(24)00682.
    PubMed        


    Pediatrics

  37. VALLECILLO-VIEJO I, Kubala S
    Redox Regulation of m6A Methyltransferase METTL3 in beta-Cells Controls the Innate Immune Response in Type 1 Diabetes.
    Pediatrics. 2024;154.
    PubMed        


    PLoS Genet

  38. BOCHER O, Singh A, Huang Y, Vosa U, et al
    Disentangling the consequences of type 2 diabetes on targeted metabolite profiles using causal inference and interaction QTL analyses.
    PLoS Genet. 2024;20:e1011346.
    PubMed         Abstract available


    PLoS One

  39. BURNETT ACR, Williamson J, Roberts AGK, Marashi-Pour S, et al
    Patient reported experiences and readmissions for people with diabetes-related foot disease admitted to public hospitals, New South Wales, Australia, 2019-2022.
    PLoS One. 2024;19:e0314895.
    PubMed         Abstract available

  40. HUI JCM, Du P, Webb SE, Liu JYH, et al
    Imaging analytical technique to assess gastrointestinal motility in vivo using zebrafish larvae with diabetes mellitus-like traits.
    PLoS One. 2024;19:e0314515.
    PubMed         Abstract available


  41. Retraction: Nesfatin-1 regulates the phenotype transition of cavernous smooth muscle cells by activating PI3K/AKT/mTOR signaling pathway to improve diabetic erectile dysfunction.
    PLoS One. 2024;19:e0314890.
    PubMed        

  42. ENG HM, Sveen KA, Fageras SJ, Strom MS, et al
    Introduction of electronic death notification in Norway-Impact on diabetes mortality registration.
    PLoS One. 2024;19:e0311106.
    PubMed         Abstract available

  43. LIU D, Cheng C, Zhou L, Zeng Q, et al
    Activity of glucose-6-phosphate dehydrogenease and its correlation with inflammatory factors in diabetic retinopathy.
    PLoS One. 2024;19:e0312452.
    PubMed         Abstract available

  44. WU W, Wang Y, Shao X, Huang S, et al
    GLP-1RA improves diabetic renal injury by alleviating glomerular endothelial cells pyrotosis via RXRalpha/circ8411/miR-23a-5p/ABCA1 pathway.
    PLoS One. 2024;19:e0314628.
    PubMed         Abstract available

  45. TRIPATHI P, Kadam N, Tiwari D, Vyawahare A, et al
    Correction: Oral glucose tolerance test clearance in type 2 diabetes patients who underwent remission following intense lifestyle modification: A quasi-experimental study.
    PLoS One. 2024;19:e0315024.
    PubMed         Abstract available

  46. NGUYEN CQ, Pham TTP, Phan DC, Do HT, et al
    Cohort profile of a prospective cohort study among middle-aged community-dwellers in rural Vietnam: The Khanh Hoa cardiovascular study.
    PLoS One. 2024;19:e0312525.
    PubMed         Abstract available

  47. ABATE HK, Azage AW, Zegeye AF, Tsega SS, et al
    A systematic review and meta-analysis of physical exercise non-adherence and its determinants among type 2 diabetic patients in Ethiopia.
    PLoS One. 2024;19:e0314389.
    PubMed         Abstract available

  48. XIAN H, Luo X, Liu Y, Guo B, et al
    Association between quantitative flow ratio and clinical outcomes in multivessel disease STEMI patients with diabetes mellitus.
    PLoS One. 2024;19:e0313892.
    PubMed         Abstract available

  49. PRIYONO D, Kim S
    The mediating role of depression on the link between physical activity and health-related quality of life among people with diabetes: A cross-sectional study.
    PLoS One. 2024;19:e0312774.
    PubMed         Abstract available

  50. ELMOSELHI AB, Seif Allah M, Bouzid A, Ibrahim Z, et al
    Correction: Circulating microRNAs as potential biomarkers of early vascular damage in vitamin D deficiency, obese, and diabetic patients.
    PLoS One. 2024;19:e0315309.
    PubMed         Abstract available

  51. SHRESTHA R, Aryal A, Khatiwada AP, Dhungana S, et al
    Exploring the medicine cost of managing Diabetes Mellitus in Nepal: A cross-sectional analysis of oral hypoglycaemic medications.
    PLoS One. 2024;19:e0310706.
    PubMed         Abstract available

  52. LOKTIONOVA MV, Mohammadian M, Choopani R, Kheiri S, et al
    Investigating the relationship between insulin use and all-cause mortality, breast cancer mortality, and recurrence risk in diabetic patients with breast cancer: A comprehensive systematic review and meta-analysis.
    PLoS One. 2024;19:e0314565.
    PubMed         Abstract available


  53. Correction: "I am my own doctor": A qualitative study of the perspectives and decision-making process of Muslims with diabetes on Ramadan fasting.
    PLoS One. 2024;19:e0315525.
    PubMed         Abstract available

  54. KAMAL SA, Du Y, Khalid M, Farrash M, et al
    DRSegNet: A cutting-edge approach to Diabetic Retinopathy segmentation and classification using parameter-aware Nature-Inspired optimization.
    PLoS One. 2024;19:e0312016.
    PubMed         Abstract available

  55. NGUYEN AT, Nguyen KD, Minh Le H, Nguyen TD, et al
    Social support and symptoms of antenatal depression among women screened for gestational diabetes mellitus: A cross-sectional study in Northern Vietnam (the VALID II study).
    PLoS One. 2024;19:e0314608.
    PubMed         Abstract available


    Retina

  56. CAPOROSSI T, Crincoli E, Culiersi C, Scampoli A, et al
    Decreasing outer retina traumatism of ILM peeling in diabetic eyes with foveal sparing technique.
    Retina. 2024 Nov 20. doi: 10.1097/IAE.0000000000004350.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.